Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints J Bartkova, N Rezaei, M Liontos, P Karakaidos, D Kletsas, N Issaeva, ... Nature 444 (7119), 633-637, 2006 | 2279 | 2006 |
A consensus molecular classification of muscle-invasive bladder cancer A Kamoun, A de Reyniès, Y Allory, G Sjödahl, AG Robertson, R Seiler, ... European urology 77 (4), 420-433, 2020 | 937 | 2020 |
Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer T Reinert, TV Henriksen, E Christensen, S Sharma, R Salari, H Sethi, ... JAMA oncology 5 (8), 1124-1131, 2019 | 680 | 2019 |
Diagnostic and prognostic microRNAs in stage II colon cancer T Schepeler, JT Reinert, MS Ostenfeld, LL Christensen, AN Silahtaroglu, ... Cancer research 68 (15), 6416-6424, 2008 | 622 | 2008 |
Identifying distinct classes of bladder carcinoma using microarrays L Dyrskjøt, T Thykjaer, M Kruhøffer, JL Jensen, N Marcussen, ... Nature genetics 33 (1), 90-96, 2003 | 587 | 2003 |
Comprehensive transcriptional analysis of early-stage urothelial carcinoma J Hedegaard, P Lamy, I Nordentoft, F Algaba, S Høyer, BP Ulhøi, S Vang, ... Cancer cell 30 (1), 27-42, 2016 | 583 | 2016 |
A dual program for translation regulation in cellular proliferation and differentiation H Gingold, D Tehler, NR Christoffersen, MM Nielsen, F Asmar, ... Cell 158 (6), 1281-1292, 2014 | 493 | 2014 |
Gene Expression in the Urinary Bladder: A Common Carcinoma in Situ Gene Expression Signature Exists Disregarding Histopathological Classification L Dyrskjøt, M Kruhøffer, T Thykjaer, N Marcussen, JL Jensen, K Møller, ... Cancer research 64 (11), 4040-4048, 2004 | 480 | 2004 |
Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro L Dyrskjøt, MS Ostenfeld, JB Bramsen, AN Silahtaroglu, P Lamy, ... Cancer research 69 (11), 4851-4860, 2009 | 457 | 2009 |
Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis K Thorsen, KD Sørensen, AS Brems-Eskildsen, C Modin, M Gaustadnes, ... Molecular & Cellular Proteomics 7 (7), 1214-1224, 2008 | 452 | 2008 |
Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer ED Wiklund, JB Bramsen, T Hulf, L Dyrskjøt, R Ramanathan, TB Hansen, ... International journal of cancer 128 (6), 1327-1334, 2011 | 436 | 2011 |
Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma E Christensen, K Birkenkamp-Demtröder, H Sethi, S Shchegrova, R Salari, ... Journal of Clinical Oncology 37 (18), 1547-1557, 2019 | 399 | 2019 |
Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue J Hedegaard, K Thorsen, MK Lund, AMK Hein, SJ Hamilton-Dutoit, ... PloS one 9 (5), e98187, 2014 | 367 | 2014 |
Comparative analysis of discrete exosome fractions obtained by differential centrifugation DK Jeppesen, ML Hvam, B Primdahl-Bengtson, AT Boysen, B Whitehead, ... Journal of extracellular vesicles 3 (1), 25011, 2014 | 357 | 2014 |
Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome Y Allory, W Beukers, A Sagrera, M Flández, M Marqués, M Márquez, ... European urology 65 (2), 360-366, 2014 | 301 | 2014 |
Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties MS Ostenfeld, DK Jeppesen, JR Laurberg, AT Boysen, JB Bramsen, ... Cancer research 74 (20), 5758-5771, 2014 | 300 | 2014 |
Pervasive chromosomal instability and karyotype order in tumour evolution TBK Watkins, EL Lim, M Petkovic, S Elizalde, NJ Birkbak, GA Wilson, ... Nature 587 (7832), 126-132, 2020 | 275 | 2020 |
Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification AN Silahtaroglu, D Nolting, L Dyrskjøt, E Berezikov, M Møller, ... Nature protocols 2 (10), 2520-2528, 2007 | 262 | 2007 |
Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer AB Als, L Dyrskjøt, H von der Maase, K Koed, F Mansilla, HE Toldbod, ... Clinical Cancer Research 13 (15), 4407-4414, 2007 | 251 | 2007 |
Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers T Reinert, C Modin, FM Castano, P Lamy, TK Wojdacz, LL Hansen, C Wiuf, ... Clinical cancer research 17 (17), 5582-5592, 2011 | 229 | 2011 |